USPTO serial 79311483
AM-PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- AVENT, TEAGUE A
- Law office
- TMO LAW OFFICE 126
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AM-PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James C. Watson
James C. Watson TraskBritt, P.C.230 South 500 East, #300Salt Lake City, UT 84102UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, medical and veterinary preparations for the treatment and prevention of kidney diseases and kidney dysfunction; plasters for medical purposes, adhesive bandages; disinfectants; dietary supplements for medical purposes; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of kidney disease and kidney dysfunction; pharmaceutical drugs for the treatment of kidney diseases and kidney dysfunction; pharmaceutical preparations to treat kidney diseases and kidney dysfunction | ACTIVE | — |
| 042 | Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, diagnostics, drugs, personal care products, and devices for others in the field of kidney disease and kidney dysfunction; biotechnological research in the field of enzymatic synthesis; testing, authentication and quality control; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; pharmaceutical research; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical development of drugs; testing of pharmaceutical products; pharmaceutical drug development services; consulting in the field of pharmaceutical research; clinical research and research in the medical field relating to kidney disease and kidney dysfunction; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for others in the field of pharmaceutical products for the treatment of kidney disease and kidney dysfunction | ACTIVE | — |
| 044 | Provision of short-term care medical services in intensive care units and hospitals; services of hygiene and beauty care for people; consultancy and information related to short-term care biopharmaceutical products provided in intensive care units and hospitals; short-term care pharmaceutical consultancy provided in intensive care units and hospitals; provision of news and information in the field of short-term care medicines provided in intensive care units and hospitals; medical services for diagnosis of diseases of the human body provided in intensive care units and hospitals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 13, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 19, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 19, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 19, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 19, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 19, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 14, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 26, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 26, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 11, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |